IP Library › Granted Patent US 11,926,609
Granted Patent B1
US 11,926,609 · App. 18/379,964 · Granted Mar 12, 2024

6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile as antimicrobial compounds

Inventors: Mai Mostafa Khalaf Ali (Al-Ahsa, SA); Hany Mohamed Abd Al-Lateef Ahmed (Al-Ahsa, SA); Antar Ahmed Abdelhamid Ahmed (Sohag, EG); Amer A. Amer (Sohag, EG)
Assignee: KING FAISAL UNIVERSITY
C07D401/04A61P31/04A61P31/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,926,609
App. No.
18/379,964
Granted
Mar 12, 2024
Kind
B1
Abstract

A 6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile compound, its synthesis, and its use as an antimicrobial agent.

Claims (20)

1. A 6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile compound having the formula I:

wherein R is ethyl.

2. The 6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile compound of claim 1 , wherein the 6′-(3-chlorophenyl)-2′ethoxy-3,4′-bipyridine-3′-carbonitrile compound is formed as crystals.

3. A pharmaceutically acceptable composition comprising a therapeutically effective amount of the 6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile compound of claim 1 and a pharmaceutically acceptable carrier.

4. A method of treating a microbial infection in a patient comprising administering to a patient in need thereof a therapeutically effective amount of the 6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile compound of claim 1 .

5. The method of treating the microbial infection of claim 4 , wherein the microbial infection is caused by one or more bacteria or fungi.

6. The method of treating the microbial infection of claim 5 , wherein the microbial infection is caused by one or more gram positive bacteria, one or more gram negative bacteria, one or more fungi, or a combination thereof.

7. The method of treating the microbial infection of claim 6 , wherein the one or more gram positive bacteria are Bacillus cereus, Staphylococcus aureus , or a combination thereof.

8. The method of treating the microbial infection of claim 6 , wherein the one or more gram negative bacteria are Pseudomonas aeruginosa, Escherichia coli , or a combination thereof.

9. The method of treating the microbial infection of claim 6 , wherein the one or more fungi are Aspergillus flavus, Chrysosporium keratinophilum , or a combination thereof.

10. A method of making the 6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile compound of claim 1 , the method comprising:

adding a mixture of 1-(3-chlorophenyl)ethan-1-one and 3-pyridine carboxaldehyde to a solution of sodium ethoxide in an absolute ethanol with stirring to obtain a first reaction mixture;

adding malononitrile to the first reaction mixture to obtain a second reaction mixture;

irradiating the second reaction mixture followed by cooling to room temperature to obtain a solid precipitate;

purifying the solid precipitate by filtering and recrystallization using the absolute ethanol; and

obtaining the 6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile compound.

11. The method of making the 6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile compound of claim 10 , wherein the first reaction mixture is stirred for about 15 minutes.

12. The method of making the 6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile compound of claim 10 , wherein the irradiating step is conducted in an MW oven and lasts for about 5 minutes.

13. The method of making the 6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile compound of claim 10 , wherein the compound is obtained in a yield of about 75%.

14. The method of making the 6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile compound of claim 10 , wherein the 1-(3-chlorophenyl)ethan-1-one, 3-pyridine carboxaldehyde, and malononitrile can be added in a 1:1:1 molar ratio.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2023
From: ALI, MAI MOSTAFA KHALAF; AHMED, HANY MOHAMED ABD EL-LATEEF; AHMED, ANTAR AHMED ABDELHAMID; AMER, AMER A.
To: KING FAISAL UNIVERSITY
Reel/Frame 065247/0099 →